GenoTwin
GenoTwin helps clinicians, public health officials, and researchers detect and track infectious pathogens and assess immune responses using genomic data. The company combines next-generation sequencing, computational biology, and AI-driven analytics as a genomics platform for pathogen detection, surveillance, immune/resistance assessment, and precision treatment. GenoTwin is positioned as a B2B SaaS/analysis provider used by public health agencies, clinical labs, and research institutions. The platform originated from Columbia University research and emphasizes applied genomics workflows and data science for infectious disease challenges. It targets public-health and clinical markets focused on pathogen monitoring and precision infectious-disease interventions.
GenoTwin
GenoTwin helps clinicians, public health officials, and researchers detect and track infectious pathogens and assess immune responses using genomic data. The company combines next-generation sequencing, computational biology, and AI-driven analytics as a genomics platform for pathogen detection, surveillance, immune/resistance assessment, and precision treatment. GenoTwin is positioned as a B2B SaaS/analysis provider used by public health agencies, clinical labs, and research institutions. The platform originated from Columbia University research and emphasizes applied genomics workflows and data science for infectious disease challenges. It targets public-health and clinical markets focused on pathogen monitoring and precision infectious-disease interventions.